middle.news
Edwards finds another growth engine in mitral and tricuspid therapies
8:21am on Thursday 5th of November, 2026 AEDT
•
Healthcare
Read Story
Edwards finds another growth engine in mitral and tricuspid therapies
8:21am on Thursday 5th of November, 2026 AEDT
Key Points
Quarterly sales up 10.5% to US$1.72 billion
TMTT revenue jumps 44% to approximately US$207 million
Adjusted EPS rises 19% to US$0.80
Full-year sales, TAVR, TMTT and adjusted EPS guidance raised
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Edwards Lifesciences (NYSE:EW)
OPEN ARTICLE